Drawing for K2 THERAPEUTICS

USPTO serial 99061027

K2 THERAPEUTICS

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
Examiner
GUTTADAURO, JULIE MARIE
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with K2 THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $249*

Plus Government fees of $150

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kristin H. Altoff, Esq.

Kristin H. Altoff, Esq. Morgan, Lewis & Bockius LLP1111 Pennsylvania Avenue, NWWashington, DC 20004-2541United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products for the prevention and treatment of disease, namely, cancer, autoimmune diseases and immunological diseases; therapeutic pharmaceuticals for the treatment of cancer, autoimmune diseases and immunological diseases; pharmaceuticals being medicines comprised of small molecules, cell therapies, nucleic acids and biologics for treatment of cancer, autoimmune diseases and immunological diseases; pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer, autoimmune diseases and immunological diseases, and for use in the fields of oncology, auto-immunity and immunologyACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 23, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 22, 2026NOACCORRECTED NOA E-MAILED
Jul 22, 2026EX1GSOU EXTENSION 1 GRANTED
Jul 22, 2026DPCCDIVISIONAL PROCESSING COMPLETE
Jul 8, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 15, 2026DRRRDIVISIONAL REQUEST RECEIVED
Apr 15, 2026ERTDTEAS REQUEST TO DIVIDE RECEIVED
Apr 15, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 15, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 14, 2026EXT1SOU EXTENSION 1 FILED
Nov 4, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 9, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 9, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 3, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 8, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 8, 2025XAECEXAMINER'S AMENDMENT ENTERED
Aug 8, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 8, 2025GNEAEXAMINERS AMENDMENT E-MAILED
Aug 8, 2025CNEAEXAMINERS AMENDMENT -WRITTEN
Aug 7, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 7, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 7, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 3, 2025DOCKASSIGNED TO EXAMINER
Jul 22, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 28, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Feb 28, 2025NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance